Corrigendum to “Empagliflozin rescues diabetic myocardial microvascular injury via AMPK-mediated inhibition of mitochondrial fission” [Redox Biol. 15 (2018) 335–346, (S2213231717309072), (10.1016/j.redox.2017.12.019)];Empagliflozin rescues diabetic myocardial microvascular injury via AMPK-mediated inhibition of mitochondrial fission

Redox Biology

Volumn 15, Issue , 2018, Pages 335-346

  Zhou, Hao ^a   Wang, Shuyi ^b   Zhu, Pingjun ^a   Hu, Shunying ^a   Chen, Yundai ^a   Ren, Jun ^b,c  

^a CHINESE PLA GENERAL HOSPITAL   (China)

^b UNIVERSITY OF WYOMING COLLEGE OF HEALTH SCIENCES   (United States)

^c ZHONGSHAN HOSPITAL OF FUDAN UNIVERSITY   (China)

Author keywords

AMPK; CMECs; Empagliflozin; Microvascular; Mitochondrial fission

Indexed keywords

DYNAMIN; DYNAMIN RELATED PROTEIN 1; EMPAGLIFLOZIN; ENDOTHELIAL NITRIC OXIDE SYNTHASE; F ACTIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG; AMP-ACTIVATED PROTEIN KINASE KINASE; BENZHYDRYL DERIVATIVE; GLUCOSIDE; PROTEIN KINASE;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD VESSEL FUNCTION; CAPILLARY DENSITY; CAPILLARY ENDOTHELIAL CELL; CARDIAC MUSCLE; CELL AGING; CELL FUNCTION; CELL MIGRATION; CELLULAR, SUBCELLULAR AND MOLECULAR BIOLOGICAL PHENOMENA AND FUNCTIONS; CONTROLLED STUDY; DEPOLYMERIZATION; DIABETIC ANGIOPATHY; DRUG EFFECT; DRUG MECHANISM; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; HEART FUNCTION; HEART MITOCHONDRION; HEART MUSCLE INJURY; MICROANGIOPATHY; MITOCHONDRIAL FISSION; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; STREPTOZOTOCIN-INDUCED DIABETES MELLITUS; VASCULAR ENDOTHELIUM; VASODILATATION; ANIMAL; COMPLICATION; ENDOTHELIUM CELL; GENETICS; HEART INJURY; HUMAN; METABOLISM; MITOCHONDRIAL DYNAMICS; MITOCHONDRION; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOLOGY;

ANIMALS; BENZHYDRYL COMPOUNDS; DIABETES MELLITUS, TYPE 2; ENDOTHELIAL CELLS; GLUCOSIDES; HEART INJURIES; HUMANS; MICE; MITOCHONDRIA; MITOCHONDRIAL DYNAMICS; PROTEIN KINASES;

EID: 85039943841     PISSN: 22132317     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.redox.2024.103083     Document Type: Erratum

References (58)

1. Zhou, H., Hu, S., Jin, Q., Shi, C., Zhang, Y., Zhu, P., Ma, Q., Tian, F., Chen, Y., Mff-dependent mitochondrial fission contributes to the pathogenesis of cardiac microvasculature ischemia/reperfusion injury via induction of mROS-mediated cardiolipin oxidation and HK2/VDAC1 disassociation-involved mPTP opening. J. Am. Heart Assoc., 6(3), 2017.
2. Sawada, N., Jiang, A., Takizawa, F., Safdar, A., Manika, A., Tesmenitsky, Y., Kang, K.T., Bischoff, J., Kalwa, H., Sartoretto, J.L., Kamei, Y., Benjamin, L.E., Watada, H., Ogawa, Y., Higashikuni, Y., Kessinger, C.W., Jaffer, F.A., Michel, T., Sata, M., Croce, K., Tanaka, R., Arany, Z., Endothelial PGC-1alpha mediates vascular dysfunction in diabetes. Cell Metab. 19:2 (2014), 246–258.
3. Hamilton, S.J., Chew, G.T., Watts, G.F., Therapeutic regulation of endothelial dysfunction in type 2 diabetes mellitus. Diabetes Vasc. Dis. Res. 4:2 (2007), 89–102.
4. Eelen, G., De Zeeuw, P., Simons, M., Carmeliet, P., Endothelial cell metabolism in normal and diseased vasculature. Circ. Res. 116:7 (2015), 1231–1244.
5. Steven, S., Oelze, M., Hanf, A., Kroller-Schon, S., Kashani, F., Roohani, S., Welschof, P., Kopp, M., Godtel-Armbrust, U., Xia, N., Li, H., Schulz, E., Lackner, K.J., Wojnowski, L., Bottari, S.P., Wenzel, P., Mayoux, E., Munzel, T., Daiber, A., The SGLT2 inhibitor empagliflozin improves the primary diabetic complications in ZDF rats. Redox Biol. 13 (2017), 370–385.
6. Zinman, B., Lachin, J.M., Inzucchi, S.E., Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes. N. Engl. J. Med., 374(11), 2016, 1094.
7. Zinman, B., Wanner, C., Lachin, J.M., Fitchett, D., Bluhmki, E., Hantel, S., Mattheus, M., Devins, T., Johansen, O.E., Woerle, H.J., Broedl, U.C., Inzucchi, S.E., O, E.-R., Investigators, empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes. N. Engl. J. Med. 373:22 (2015), 2117–2128.
8. Cefalu, W.T., Paradoxical insights into whole body metabolic adaptations following SGLT2 inhibition. J. Clin. Invest. 124:2 (2014), 485–487.
9. Dixon, J.B., Obesity in 2015: advances in managing obesity. Nat. Rev. Endocrinol. 12:2 (2016), 65–66.
10. Quintero, M., Colombo, S.L., Godfrey, A., Moncada, S., Mitochondria as signaling organelles in the vascular endothelium. Proc. Natl. Acad. Sci. USA 103:14 (2006), 5379–5384.
11. Fuhrmann, D.C., Brune, B., Mitochondrial composition and function under the control of hypoxia. Redox Biol. 12 (2017), 208–215.
12. Wang, W., Wang, Y., Long, J., Wang, J., Haudek, S.B., Overbeek, P., Chang, B.H., Schumacker, P.T., Danesh, F.R., Mitochondrial fission triggered by hyperglycemia is mediated by ROCK1 activation in podocytes and endothelial cells. Cell Metab. 15:2 (2012), 186–200.
13. Makino, A., Scott, B.T., Dillmann, W.H., Mitochondrial fragmentation and superoxide anion production in coronary endothelial cells from a mouse model of type 1 diabetes. Diabetologia 53:8 (2010), 1783–1794.
14. Zhou, H., Zhu, P., Guo, J., Hu, N., Wang, S., Li, D., Hu, S., Ren, J., Cao, F., Chen, Y., Ripk3 induces mitochondrial apoptosis via inhibition of FUNDC1 mitophagy in cardiac IR injury. Redox Biol. 13 (2017), 498–507.
15. Zhou, H., Du, W., Li, Y., Shi, C., Hu, N., Ma, S., Wang, W., Ren, J., Effects of melatonin on fatty liver disease: the role of NR4A1/DNA-PKcs/p53 pathway, mitochondrial fission, and mitophagy. J. Pineal Res., 64(1), 2018.
16. Ding, M., Ning, J., Feng, N., Li, Z., Liu, Z., Wang, Y., Wang, Y., Li, X., Huo, C., Jia, X., Xu, R., Fu, F., Wang, X., Pei, J., Dynamin-related protein 1-mediated mitochondrial fission contributes to post-traumatic cardiac dysfunction in rats and the protective effect of melatonin. J. Pineal Res., 64(1), 2018.
17. Yang, X., Wang, H., Ni, H.M., Xiong, A., Wang, Z., Sesaki, H., Ding, W.X., Yang, L., Inhibition of Drp1 protects against senecionine-induced mitochondria-mediated apoptosis in primary hepatocytes and in mice. Redox Biol. 12 (2017), 264–273.
18. Park, S.J., Lee, H., Jo, D.S., Jo, Y.K., Shin, J.H., Kim, H.B., Seo, H.M., Rubinsztein, D.C., Koh, J.Y., Lee, E.K., Cho, D.H., Heterogeneous nuclear ribonucleoprotein A1 post-transcriptionally regulates Drp1 expression in neuroblastoma cells. Biochim. Biophys. Acta 1849:12 (2015), 1423–1431.
19. Kashatus, D.F., Restraining the divider: a Drp1-phospholipid interaction inhibits Drp1 activity and shifts the balance from mitochondrial fission to fusion. Mol. Cell 63:6 (2016), 913–915.
20. Wang, Q., Zhang, M., Torres, G., Wu, S., Ouyang, C., Xie, Z., Zou, M.H., Metformin suppresses diabetes-accelerated atherosclerosis via the inhibition of Drp1-mediated mitochondrial fission. Diabetes 66:1 (2017), 193–205.
21. Zhou, H., Zhang, Y., Hu, S., Shi, C., Zhu, P., Ma, Q., Jin, Q., Cao, F., Tian, F., Chen, Y., Melatonin protects cardiac microvasculature against ischemia/reperfusion injury via suppression of mitochondrial fission-VDAC1-HK2-mPTP-mitophagy axis. J. Pineal Res., 63(1), 2017.
22. Zhang, Y., Zhou, H., Wu, W., Shi, C., Hu, S., Yin, T., Ma, Q., Han, T., Zhang, Y., Tian, F., Chen, Y., Liraglutide protects cardiac microvascular endothelial cells against hypoxia/reoxygenation injury through the suppression of the SR-Ca(2+)-XO-ROS axis via activation of the GLP-1R/PI3K/Akt/survivin pathways. Free Radic. Biol. Med. 95 (2016), 278–292.
23. Lee, H.J., Jung, Y.H., Choi, G.E., Ko, S.H., Lee, S.J., Lee, S.H., Han, H.J., BNIP3 induction by hypoxia stimulates FASN-dependent free fatty acid production enhancing therapeutic potential of umbilical cord blood-derived human mesenchymal stem cells. Redox Biol. 13 (2017), 426–443.
24. Das, N., Mandala, A., Naaz, S., Giri, S., Jain, M., Bandyopadhyay, D., Reiter, R.J., Roy, S.S., Melatonin protects against lipid-induced mitochondrial dysfunction in hepatocytes and inhibits stellate cell activation during hepatic fibrosis in mice. J. Pineal Res., 62(4), 2017.
25. Zhou, H., Li, D., Shi, C., Xin, T., Yang, J., Zhou, Y., Hu, S., Tian, F., Wang, J., Chen, Y., Effects of Exendin-4 on bone marrow mesenchymal stem cell proliferation, migration and apoptosis in vitro. Sci. Rep., 5, 2015, 12898.
26. Zhou, H., Yang, J., Xin, T., Zhang, T., Hu, S., Zhou, S., Chen, G., Chen, Y., Exendin-4 enhances the migration of adipose-derived stem cells to neonatal rat ventricular cardiomyocyte-derived conditioned medium via the phosphoinositide 3-kinase/Akt-stromal cell-derived factor-1alpha/CXC chemokine receptor 4 pathway. Mol. Med. Rep. 11:6 (2015), 4063–4072.
27. Yang, X., Xu, Y., Wang, T., Shu, D., Guo, P., Miskimins, K., Qian, S.Y., Inhibition of cancer migration and invasion by knocking down delta-5-desaturase in COX-2 overexpressed cancer cells. Redox Biol. 11 (2017), 653–662.
28. Gao, Y., Xiao, X., Zhang, C., Yu, W., Guo, W., Zhang, Z., Li, Z., Feng, X., Hao, J., Zhang, K., Xiao, B., Chen, M., Huang, W., Xiong, S., Wu, X., Deng, W., Melatonin synergizes the chemotherapeutic effect of 5-fluorouracil in colon cancer by suppressing PI3K/AKT and NF-kappaB/iNOS signaling pathways. J. Pineal Res., 62(2), 2017.
29. Malinda, K.M., In vivo matrigel migration and angiogenesis assay. Methods Mol. Biol. 467 (2009), 287–294.
30. Sigala, F., Efentakis, P., Karageorgiadi, D., Filis, K., Zampas, P., Iliodromitis, E.K., Zografos, G., Papapetropoulos, A., Andreadou, I., Reciprocal regulation of eNOS, H2S and CO-synthesizing enzymes in human atheroma: correlation with plaque stability and effects of simvastatin. Redox Biol. 12 (2017), 70–81.
31. Yu, S., Wang, X., Geng, P., Tang, X., Xiang, L., Lu, X., Li, J., Ruan, Z., Chen, J., Xie, G., Wang, Z., Ou, J., Peng, Y., Luo, X., Zhang, X., Dong, Y., Pang, X., Miao, H., Chen, H., Liang, H., Melatonin regulates PARP1 to control the senescence-associated secretory phenotype (SASP) in human fetal lung fibroblast cells. J. Pineal Res., 63(1), 2017.
32. Zhou, H., Li, D., Zhu, P., Hu, S., Hu, N., Ma, S., Zhang, Y., Han, T., Ren, J., Cao, F., Chen, Y., Melatonin suppresses platelet activation and function against cardiac ischemia/reperfusion injury via PPARgamma/FUNDC1/mitophagy pathways. J. Pineal Res., 63(4), 2017.
33. Jin, Q., Li, R., Hu, N., Xin, T., Zhu, P., Hu, S., Ma, S., Zhu, H., Ren, J., Zhou, H., DUSP1 alleviates cardiac ischemia/reperfusion injury by suppressing the Mff-required mitochondrial fission and Bnip3-related mitophagy via the JNK pathways. Redox Biol. 14 (2018), 576–587.
34. Shi, C., Cai, Y., Li, Y., Li, Y., Hu, N., Ma, S., Hu, S., Zhu, P., Wang, W., Zhou, H., Yap promotes hepatocellular carcinoma metastasis and mobilization via governing cofilin/F-actin/lamellipodium axis by regulation of JNK/Bnip3/SERCA/CaMKII pathways. Redox Biol. 14 (2018), 59–71.
35. Kaul, S., Is the mortality benefit with empagliflozin in type 2 diabetes mellitus too good to be true?. Circulation 134:2 (2016), 94–96.
36. Rosenson, R.S., Fioretto, P., Dodson, P.M., Does microvascular disease predict macrovascular events in type 2 diabetes?. Atherosclerosis 218:1 (2011), 13–18.
37. Katakam, P.V., Wappler, E.A., Katz, P.S., Rutkai, I., Institoris, A., Domoki, F., Gaspar, T., Grovenburg, S.M., Snipes, J.A., Busija, D.W., Depolarization of mitochondria in endothelial cells promotes cerebral artery vasodilation by activation of nitric oxide synthase. Arterioscler. Thromb. Vasc. Biol. 33:4 (2013), 752–759.
38. Chilton, R., Tikkanen, I., Cannon, C.P., Crowe, S., Woerle, H.J., Broedl, U.C., Johansen, O.E., Effects of empagliflozin on blood pressure and markers of arterial stiffness and vascular resistance in patients with type 2 diabetes. Diabetes Obes. Metab. 17:12 (2015), 1180–1193.
39. Gilbert, R.E., Krum, H., Heart failure in diabetes: effects of anti-hyperglycaemic drug therapy. Lancet 385:9982 (2015), 2107–2117.
40. Sarwar, C.M., Papadimitriou, L., Pitt, B., Pina, I., Zannad, F., Anker, S.D., Gheorghiade, M., Butler, J., Hyperkalemia in heart failure. J. Am. Coll. Cardiol. 68:14 (2016), 1575–1589.
41. Wang, D., Luo, P., Wang, Y., Li, W., Wang, C., Sun, D., Zhang, R., Su, T., Ma, X., Zeng, C., Wang, H., Ren, J., Cao, F., Glucagon-like peptide-1 protects against cardiac microvascular injury in diabetes via a cAMP/PKA/Rho-dependent mechanism. Diabetes 62:5 (2013), 1697–1708.
42. Xu, S., Pi, H., Zhang, L., Zhang, N., Li, Y., Zhang, H., Tang, J., Li, H., Feng, M., Deng, P., Guo, P., Tian, L., Xie, J., He, M., Lu, Y., Zhong, M., Zhang, Y., Wang, W., Reiter, R.J., Yu, Z., Zhou, Z., Melatonin prevents abnormal mitochondrial dynamics resulting from the neurotoxicity of cadmium by blocking calcium-dependent translocation of Drp1 to the mitochondria. J. Pineal Res. 60:3 (2016), 291–302.
43. Bereiter-Hahn, J., Voth, M., Mai, S., Jendrach, M., Structural implications of mitochondrial dynamics. Biotechnol. J. 3:6 (2008), 765–780.
44. Hatch, A.L., Ji, W.K., Merrill, R.A., Strack, S., Higgs, H.N., Actin filaments as dynamic reservoirs for Drp1 recruitment. Mol. Biol. Cell 27:20 (2016), 3109–3121.
45. Liu, Y., Li, H., Bubolz, A.H., Zhang, D.X., Gutterman, D.D., Endothelial cytoskeletal elements are critical for flow-mediated dilation in human coronary arterioles. Med. Biol. Eng. Comput. 46:5 (2008), 469–478.
46. Li, S., Xu, S., Roelofs, B.A., Boyman, L., Lederer, W.J., Sesaki, H., Karbowski, M., Transient assembly of F-actin on the outer mitochondrial membrane contributes to mitochondrial fission. J. Cell Biol. 208:1 (2015), 109–123.
47. Preau, S., Delguste, F., Yu, Y., Remy-Jouet, I., Richard, V., Saulnier, F., Boulanger, E., Neviere, R., Endotoxemia engages the RhoA kinase pathway to impair cardiac function by altering cytoskeleton, mitochondrial fission, and autophagy. Antioxid. Redox Signal. 24:10 (2016), 529–542.
48. Prudent, J., Mcbride, H.M., Mitochondrial dynamics: ER actin tightens the Drp1 noose. Curr. Biol. 26:5 (2016), R207–R209.
49. Zhang, C.S., Lin, S.C., AMPK promotes autophagy by facilitating mitochondrial fission. Cell Metab. 23:3 (2016), 399–401.
50. Toyama, E.Q., Herzig, S., Courchet, J., Lewis, T.L. Jr., Loson, O.C., Hellberg, K., Young, N.P., Chen, H., Polleux, F., Chan, D.C., Shaw, R.J., Metabolism. AMP-activated protein kinase mediates mitochondrial fission in response to energy stress. Science 351:6270 (2016), 275–281.
51. Kang, J.W., Hong, J.M., Lee, S.M., Melatonin enhances mitophagy and mitochondrial biogenesis in rats with carbon tetrachloride-induced liver fibrosis. J. Pineal Res. 60:4 (2016), 383–393.
52. Li, J., Wang, Y., Wang, Y., Wen, X., Ma, X.N., Chen, W., Huang, F., Kou, J., Qi, L.W., Liu, B., Liu, K., Pharmacological activation of AMPK prevents Drp1-mediated mitochondrial fission and alleviates endoplasmic reticulum stress-associated endothelial dysfunction. J. Mol. Cell. Cardiol. 86 (2015), 62–74.
53. Rovira-Llopis, S., Banuls, C., Diaz-Morales, N., Hernandez-Mijares, A., Rocha, M., Victor, V.M., Mitochondrial dynamics in type 2 diabetes: pathophysiological implications. Redox Biol. 11 (2017), 637–645.
54. Zhu, H., Jin, Q., Li, Y., Ma, Q., Wang, J., Li, D., Zhou, H., Chen, Y., Melatonin protected cardiac microvascular endothelial cells against oxidative stress injury via suppression of IP3R-[Ca(2+)]c/VDAC-[Ca(2+)]m axis by activation of MAPK/ERK signaling pathway. Cell Stress Chaperon., 2017.
55. Suarez-Rivero, J.M., Villanueva-Paz, M., De La Cruz-Ojeda, P., De La Mata, M., Cotan, D., Oropesa-Avila, M., De Lavera, I., Alvarez-Cordoba, M., Luzon-Hidalgo, R., Sanchez-Alcazar, J.A., Mitochondrial dynamics in mitochondrial diseases. Diseases, 5(1), 2016.
56. Onphachanh, X., Lee, H.J., Lim, J.R., Jung, Y.H., Kim, J.S., Chae, C.W., Lee, S.J., Gabr, A.A., Han, H.J., Enhancement of high glucose-induced PINK1 expression by melatonin stimulates neuronal cell survival: involvement of MT2/Akt/NF-kappaB pathway. J. Pineal Res., 63(2), 2017.
57. Bertero, E., Prates Roma, L., Ameri, P., Maack, C., Cardiac effects of SGLT2 inhibitors: the sodium hypothesis. Cardiovasc. Res., 2017.
58. Shi, X., Verma, S., Yun, J., Brand-Arzamendi, K., Singh, K.K., Liu, X., Garg, A., Quan, A., Wen, X.Y., Effect of empagliflozin on cardiac biomarkers in a zebrafish model of heart failure: clues to the EMPA-REG OUTCOME trial?. Mol. Cell. Biochem. 433:1–2 (2017), 97–102.